Tag: regulatory strategy

National Heart, Lung, and Blood Institute / National Institutes of Health Signs Clinical Trial Agreement with Vascarta Inc. to Perform Phase 1 Clinical Study...

SUMMIT, N.J., July 7, 2025 /PRNewswire/ -- Under the agreement, the National Heart, Lung, and Blood Institute / National Institutes of Health will perform...

Relm Appoints Dr Rayyan Zafar As Senior Scientific Advisor As Part Of Strategic Expansion In Alternative Therapeutics Sector

Bermuda, July 01, 2025 (GLOBE NEWSWIRE) -- - Relm Insurance (‘Relm’), the leading insurer for emerging and innovative industries, today announced the appointment of Dr. Rayyan Zafar, PhD, MRSB, as a Senior Scientific Advisor to the firm. In this role, Dr. Zafar will inform Relm’s strategic expansion into the emerging field of Psychedelics and Alternative Therapeutics, leveraging his world-class expertise to deepen Relm’s understanding of novel treatments for addiction and mental health disorders.

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsRegulatory strategy

Paralyzed Veterans of America Releases Statement Following Department of Veterans Affairs’ Announcement Not to Pursue Large-Scale Reduction-in-Force

Monarch Casino & Resort to Report 2025 Second Quarter Results After Market Close on July 16

INTERRENT REIT ANNOUNCES END OF “GO-SHOP” PERIOD

Tag: regulatory strategy

National Heart, Lung, and Blood Institute / National Institutes of Health Signs Clinical Trial Agreement with Vascarta Inc. to Perform Phase 1 Clinical Study...

Relm Appoints Dr Rayyan Zafar As Senior Scientific Advisor As Part Of Strategic Expansion In Alternative Therapeutics Sector

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us